CVE-2026-21923
CVE-2026-21923
Vexday Risk Score
13Bajo
Decisión SSVC (CISA)
Track
Sin señal de explotación → monitorear
CVSS 6.5EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch referenciado
Ciclo de vida
20 ene 2026Publicada en NVD
Recomendación: Monitorear — sin señal de explotación por ahora.
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Productos afectados
Oracle Corporation · Oracle Life Sciences Central Designer